Receptor-mediated Targeting

Receptor-Mediated Targeting is an active targeted drug delivery strategy that exploits specific interactions between ligands on a therapeutic agent or carrier and cell-surface receptors, typically overexpressed on diseased cells relative to normal tissue, to achieve selective binding, internalization, and accumulation of the drug at the intended site of action.

747

Publications

50.6K

Citations

4.8K

Authors

1.1K

Institutions

Publications per year

2017–2026

267

Authors

4.8K

  1. PS
    Philip S. Low

    Purdue University West Lafayette, United States

    16 publications · 2K citations

    15

    h-index

  2. DT
    David T. Curiel

    University of Alabama at Birmingham, United States

    13 publications · 892 citations

    12

    h-index

  3. RP
    Renata Pasqualini

    The University of Texas MD Anderson Cancer Center, United States

    9 publications · 2.8K citations

    9

    h-index

  4. TJ
    Thomas J. Wickham

    GenVec, United States

    8 publications · 1.2K citations

    8

    h-index

  5. EW
    Ernst Wagner

    Ludwig-Maximilians-Universität München, Germany

    7 publications · 199 citations

    7

    h-index

1–5 of 4.8K

Venues

  1. Journal of Controlled Release

    26 publications · 2.5K citations

    21

    h-index

  2. Bioconjugate Chemistry

    22 publications · 2K citations

    20

    h-index

  3. PubMed

    Repository · 24 publications · 1.5K citations

    19

    h-index

  4. Proceedings of the National Academy of Sciences

    PNAS · 17 publications · 1.4K citations

    16

    h-index

  5. Biomaterials

    15 publications · 657 citations

    15

    h-index

1–5